Skip to main content

Contact Us
Investors & Media

Mission
Science
Our Medicine
Company
Responsibility
Careers

your next opportunity awaits

your next opportunity awaits

Careers / Open Opportunities

Open Opportunities Outside the US

See open US opportunities

BEWARE of email employment scams

Learn how to identify employment scams

Home
Mission
Science
Our Medicine
Company
Responsibility
Careers
Updated Privacy Policy
Cookie Policy
Terms of Use
Patent Notices

CYTOKINETICS^® and the C logo are registered trademarks of Cytokinetics in the U.S. and certain other countries.

Cytokinetics scientists and collaborators are committed to high scientific and ethical publications standards and are dedicated to providing our science to the medical and scientific community through peer-reviewed journals and medical forums. Our scientific publications (e.g., manuscripts, posters and/or oral presentations that contain data from Cytokinetics-sponsored studies, have Cytokinetics authors, or for which Cytokinetics provides writing and/or editorial assistance) are generally intended for health care professionals.

If you have specific questions or require additional information, please contact Cytokinetics Medical Information at [email protected].

Note: All content provided as is and per applicable permissions; some links provided below redirect to third-party websites that may require a subscription to access publications.

Cytokinetics scientists and collaborators are committed to high scientific and ethical research standards and are dedicated to better understanding and advancing the science of muscle biology and diseases of muscle dysfunction. Our Investigator-Initiated Research program is intended for scientists and health care professionals.

If you have specific questions or require additional information, please contact the Cytokinetics Investigator-Initiated Research team at [email protected] (clinical submissions) or [email protected] (non-clinical or pre-clinical submissions).

Note: All content provided as is and per applicable permissions; some links provided below redirect to third-party websites that may require a subscription to access publications.

We’re proud to announce that the U.S. Food and Drug Administration has approved MYQORZO™ (aficamten)!

Read our press release

Please see Full Prescribing Information, including BOXED WARNING here.